Tango Stock Based Compensation from 2010 to 2024

TNGX Stock  USD 3.10  0.16  5.44%   
Tango Therapeutics Stock Based Compensation yearly trend continues to be fairly stable with very little volatility. Stock Based Compensation will likely drop to about 9.8 M in 2024. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2010-12-31
Previous Quarter
19.1 M
Current Value
9.8 M
Quarterly Volatility
5.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tango Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tango Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.6 M, Interest Expense of 3.6 M or Selling General Administrative of 22.1 M, as well as many indicators such as Price To Sales Ratio of 19.37, Dividend Yield of 0.0 or PTB Ratio of 6.45. Tango financial statements analysis is a perfect complement when working with Tango Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tango Therapeutics Correlation against competitors.
For more information on how to buy Tango Stock please use our How to Invest in Tango Therapeutics guide.

Latest Tango Therapeutics' Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Tango Therapeutics over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Tango Therapeutics' Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tango Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

Tango Stock Based Compensation Regression Statistics

Arithmetic Mean4,643,867
Geometric Mean2,864,213
Coefficient Of Variation119.68
Mean Deviation4,317,138
Median1,694,000
Standard Deviation5,557,864
Sample Variance30.9T
Range17.4M
R-Value0.71
Mean Square Error16.3T
R-Squared0.51
Significance0
Slope887,793
Total Sum of Squares432.5T

Tango Stock Based Compensation History

20249.8 M
202319.1 M
202214.2 M
20217.8 M
20201.8 M

Other Fundumenentals of Tango Therapeutics

Tango Therapeutics Stock Based Compensation component correlations

0.980.94-0.65-0.850.961.00.921.00.98-0.84-0.75-0.510.970.940.950.930.58
0.980.97-0.71-0.820.920.970.840.980.96-0.87-0.77-0.510.990.960.980.940.57
0.940.97-0.62-0.880.880.920.770.930.94-0.87-0.85-0.640.990.980.970.930.67
-0.65-0.71-0.620.24-0.48-0.63-0.44-0.7-0.540.860.540.03-0.7-0.51-0.78-0.56-0.02
-0.85-0.82-0.880.24-0.84-0.84-0.81-0.81-0.910.640.820.85-0.83-0.94-0.76-0.79-0.89
0.960.920.88-0.48-0.840.970.940.950.94-0.7-0.61-0.440.90.90.870.960.52
1.00.970.92-0.63-0.840.970.950.990.98-0.83-0.73-0.50.950.930.930.920.57
0.920.840.77-0.44-0.810.940.950.910.91-0.68-0.61-0.470.80.810.770.820.53
1.00.980.93-0.7-0.810.950.990.910.97-0.87-0.75-0.480.970.930.960.920.54
0.980.960.94-0.54-0.910.940.980.910.97-0.78-0.76-0.620.950.980.90.90.71
-0.84-0.87-0.870.860.64-0.7-0.83-0.68-0.87-0.780.870.48-0.89-0.79-0.94-0.76-0.43
-0.75-0.77-0.850.540.82-0.61-0.73-0.61-0.75-0.760.870.84-0.81-0.82-0.81-0.65-0.77
-0.51-0.51-0.640.030.85-0.44-0.5-0.47-0.48-0.620.480.84-0.55-0.7-0.47-0.41-0.96
0.970.990.99-0.7-0.830.90.950.80.970.95-0.89-0.81-0.550.960.990.940.59
0.940.960.98-0.51-0.940.90.930.810.930.98-0.79-0.82-0.70.960.910.910.77
0.950.980.97-0.78-0.760.870.930.770.960.9-0.94-0.81-0.470.990.910.930.49
0.930.940.93-0.56-0.790.960.920.820.920.9-0.76-0.65-0.410.940.910.930.47
0.580.570.67-0.02-0.890.520.570.530.540.71-0.43-0.77-0.960.590.770.490.47
Click cells to compare fundamentals

About Tango Therapeutics Financial Statements

Tango Therapeutics investors use historical fundamental indicators, such as Tango Therapeutics' Stock Based Compensation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tango Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Stock Based Compensation19.1 M9.8 M
Stock Based Compensation To Revenue 0.52  0.55 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tango Stock Analysis

When running Tango Therapeutics' price analysis, check to measure Tango Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tango Therapeutics is operating at the current time. Most of Tango Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tango Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tango Therapeutics' price. Additionally, you may evaluate how the addition of Tango Therapeutics to your portfolios can decrease your overall portfolio volatility.